mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |